These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15471083)

  • 1. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity.
    Okada A; Yasui T; Hamamoto S; Hirose M; Kubota Y; Itoh Y; Tozawa K; Hayashi Y; Kohri K
    J Bone Miner Res; 2009 May; 24(5):908-24. PubMed ID: 19113933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
    Lieske JC; Hammes MS; Toback FG
    Scanning Microsc; 1996; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and endocytosis of calcium oxalate crystals on renal tubular cells.
    Kohjimoto Y; Ebisuno S; Tamura M; Ohkawa T
    Scanning Microsc; 1996; 10(2):459-68; discussion 468-70. PubMed ID: 9813624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor has protective effects on crystal-cell interaction and crystal deposits.
    Tei N; Tsujihata M; Tsujikawa K; Yoshimura K; Nonomura N; Okuyama A
    Urology; 2006 Apr; 67(4):864-9. PubMed ID: 16600342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells.
    Lieske JC; Deganello S
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S422-9. PubMed ID: 10541277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
    Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
    Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
    J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation.
    Okada A; Yasui T; Fujii Y; Niimi K; Hamamoto S; Hirose M; Kojima Y; Itoh Y; Tozawa K; Hayashi Y; Kohri K
    J Bone Miner Res; 2010 Dec; 25(12):2701-11. PubMed ID: 20577968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.